Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice (2021)
- Authors:
- Puhl, Ana C.
- Gomes, Giovanni Freitas
- Damasceno, Samara
- Fritch, Ethan J.
- Levi, James A.
- Johnson, Nicole J.
- Scholle, Frank
- Premkumar, Lakshmanane
- Hurst, Brett L.
- LeeMontiel, Felipe
- Veras, Flávio Protásio
- Batah, Sabrina Setembre
- Fabro, Alexandre Todorovic
- Moorman, Nathaniel J.
- Yount, Boyd L.
- Dickmander, Rebekah
- Baric, Ralph
- Pearce, Kenneth H.
- Cunha, Fernando de Queiroz
- Alves Filho, José Carlos Farias
- Cunha, Thiago Mattar
- Ekins, Sean
- USP affiliated authors: VERAS, FLÁVIO PROTÁSIO - FCFRP ; FABRO, ALEXANDRE TODOROVIC - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP ; ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; GOMES, GIOVANNI FREITAS - FMRP ; DAMASCENO, SAMARA - FMRP ; BATAH, SABRINA SETEMBRE - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1101/2021.12.16.472155
- Subjects: ANTIVIRAIS; ANTINEOPLÁSICOS; CITOCINAS; COVID-19
- Keywords: Antiviral; SARS-CoV-2; Spike protein; Entrectinib; Vandetanib
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
PUHL, Ana C. et al. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, p. 1-52, 2021Tradução . . Disponível em: https://doi.org/10.1101/2021.12.16.472155. Acesso em: 01 fev. 2025. -
APA
Puhl, A. C., Gomes, G. F., Damasceno, S., Fritch, E. J., Levi, J. A., Johnson, N. J., et al. (2021). Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice. bioRxiv, 1-52. doi:10.1101/2021.12.16.472155 -
NLM
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2025 fev. 01 ] Available from: https://doi.org/10.1101/2021.12.16.472155 -
Vancouver
Puhl AC, Gomes GF, Damasceno S, Fritch EJ, Levi JA, Johnson NJ, Scholle F, Premkumar L, Hurst BL, LeeMontiel F, Veras FP, Batah SS, Fabro AT, Moorman NJ, Yount BL, Dickmander R, Baric R, Pearce KH, Cunha F de Q, Alves Filho JCF, Cunha TM, Ekins S. Vandetanib reduces inflammatory cytokines and ameliorates COVID-19 in infected mice [Internet]. bioRxiv. 2021 ; 1-52.[citado 2025 fev. 01 ] Available from: https://doi.org/10.1101/2021.12.16.472155 - Vandetanib blocks the cytokine storm in SARS-CoV-2-infected mice
- Production and evaluation of leukocyte- and thrombocyte-rich fibrin membranes in birds
- Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians
- Targeting IL-33/ST2 signaling: regulation of immune function and analgesia
- Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects
- Pericytes modulate myelination in the central nervous system
- TGFβ1 signaling sustains aryl hydrocarbon receptor (AHR) expression and restrains the pathogenic potential of TH17 cells by an AHR-independent mechanism
- Toll-like receptor 9 activation in neutrophils impairs chemotaxis and reduces sepsis outcome
- Superoxide anion-induced pain and inflammation depends on TNFα/TNFR1 signaling in mice
- The citrus flavanone naringenin reduces gout-induced joint pain and inflammation in mice by inhibiting the activation of NFκB and macrophage release of IL-1β
Informações sobre o DOI: 10.1101/2021.12.16.472155 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
